Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23718,85,0.89 [0.45-1.75],0.7291258114923054
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24217,127,0.82 [0.48-1.42],0.4823786617453568
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",24007,891,1.05 [0.85-1.30],0.6338069130277609
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Candidiasis,24242,265,1.07 [0.73-1.58],0.7252488284724162
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23556,2408,0.98 [0.86-1.11],0.7604487624202946
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23777,1828,1.07 [0.92-1.24],0.3567271172589199
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,24065,864,0.94 [0.76-1.16],0.5747192433065573
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,24174,38,0.77 [0.29-2.06],0.5984621474880467
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,23124,561,1.07 [0.82-1.40],0.6097957997432749
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22335,534,1.18 [0.89-1.55],0.2486935264770139
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22562,152,1.36 [0.81-2.29],0.2465232489936835
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17988,1063,0.95 [0.78-1.16],0.6234157775849201
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22364,249,0.85 [0.57-1.27],0.4302597489410364
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,24208,1007,0.98 [0.81-1.19],0.835432594937608
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Mycoses,24300,323,1.08 [0.76-1.54],0.655349672053127
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23663,547,0.93 [0.71-1.21],0.5748798979382601
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24248,615,1.03 [0.80-1.32],0.839797844069686
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23330,129,0.82 [0.47-1.41],0.4652065204021052
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24341,29,0.40 [0.14-1.19],0.0998716556827906
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24176,543,1.02 [0.78-1.34],0.8863106798645791
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24199,63,0.78 [0.36-1.68],0.5224590451840945
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24253,153,0.59 [0.37-0.95],0.0307497416137033
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24238,138,0.58 [0.35-0.96],0.0330244659599387
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23417,301,1.39 [0.96-2.01],0.0853407643609639
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,23325,209,1.06 [0.69-1.64],0.7935155795843511
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,23267,66,1.33 [0.61-2.92],0.470669570566612
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24315,46,0.84 [0.33-2.10],0.7072209468698889
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24285,112,1.31 [0.72-2.37],0.3703967586613435
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Viral warts,24209,36,1.22 [0.43-3.49],0.7087160104909211
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24217,44,1.76 [0.69-4.47],0.236004747833486
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign lipomatous neoplasm,24084,276,1.10 [0.75-1.60],0.6339291572563952
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24266,66,1.26 [0.58-2.72],0.562398920613137
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24239,65,1.22 [0.56-2.68],0.6179415238781618
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10856,36,1.44 [0.47-4.37],0.5232824402063947
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",24161,1025,1.12 [0.92-1.36],0.2683607357437957
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm of meninges,24330,43,0.44 [0.18-1.04],0.0627081019224618
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24309,47,1.03 [0.41-2.59],0.9496827820079006
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24319,79,1.42 [0.69-2.90],0.3367610892289493
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm of ovary,13427,84,0.88 [0.46-1.67],0.6899629922761532
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24333,240,1.56 [1.02-2.37],0.0379720840379093
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Caecum,24329,181,1.56 [0.97-2.52],0.0669287045806341
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24275,50,1.00 [0.41-2.41],0.9921458438506222
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Descending colon,24335,156,1.32 [0.78-2.22],0.2955953369353432
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Rectum,24303,254,0.92 [0.62-1.37],0.6927821609861049
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24271,477,1.18 [0.88-1.58],0.2765126364841415
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24333,272,1.26 [0.85-1.87],0.2412017105085572
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Carcinoma in situ of breast,11505,76,2.12 [1.07-4.22],0.0323186421553283
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11545,86,1.33 [0.69-2.56],0.4021326545040919
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20992,30,1.71 [0.52-5.64],0.3761330962765261
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20996,34,0.93 [0.32-2.68],0.8915083143397846
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24303,95,1.55 [0.81-2.95],0.1823671737439461
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Haemangioma, any site",24303,93,1.48 [0.77-2.83],0.2391437923141407
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Leiomyoma of uterus,12857,348,1.04 [0.76-1.43],0.8078091375698173
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Lung cancer and mesothelioma,18032,158,0.85 [0.51-1.39],0.5109518949764522
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Lymphoid leukaemia,20990,28,1.60 [0.48-5.35],0.4443258904839184
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",21089,127,1.13 [0.65-1.97],0.6737439224900628
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",21043,81,1.27 [0.63-2.59],0.5029625120243104
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11591,69,2.59 [1.26-5.33],0.0096383800158968
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",21007,45,0.46 [0.19-1.12],0.0888532175805165
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",21016,54,1.33 [0.55-3.21],0.5192397713390378
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",21027,65,0.93 [0.42-2.06],0.8598181109618275
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11569,47,1.48 [0.61-3.62],0.3851131776548557
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",21016,54,0.97 [0.42-2.27],0.9478883062687324
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9784,344,0.97 [0.68-1.38],0.8723241576022496
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",21048,86,1.10 [0.55-2.18],0.7861870026749724
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",21011,49,1.71 [0.67-4.37],0.2661870632806055
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,21020,58,0.41 [0.19-0.87],0.0197002436255203
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Melanocytic naevi,24131,191,0.89 [0.57-1.38],0.5946900502724296
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Melanocytic naevi of trunk,24297,87,1.45 [0.74-2.85],0.2825429437563161
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Melanoma in situ,20973,41,0.68 [0.26-1.75],0.4222872425847985
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",21015,53,0.99 [0.42-2.33],0.9732285952278388
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",21063,101,1.02 [0.55-1.91],0.9429800718187212
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",21068,106,0.78 [0.44-1.40],0.4082362346523334
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",21020,58,0.77 [0.34-1.72],0.5218752113188297
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,Other benign neoplasms of skin,24182,131,0.95 [0.56-1.63],0.8623708751626532
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21531,569,0.90 [0.69-1.17],0.4311504485723006
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21560,598,0.90 [0.70-1.16],0.4327420884497694
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,24089,264,0.74 [0.51-1.07],0.1071466310470371
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,23088,40,0.66 [0.25-1.70],0.386201961274591
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23893,68,1.98 [0.91-4.29],0.0833653535237394
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23626,1965,1.10 [0.96-1.27],0.1839299364673349
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,23307,20,0.81 [0.48-1.38],0.4439511177262553
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,24026,30,0.68 [0.23-2.05],0.496069470399754
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23946,898,1.19 [0.96-1.46],0.1104414581511485
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23946,898,1.19 [0.96-1.46],0.1104414581511485
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,23097,49,0.60 [0.26-1.40],0.2384703600802402
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,24093,806,1.27 [1.02-1.59],0.0337615259235305
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,24091,95,0.75 [0.40-1.40],0.3641314053551749
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23871,46,1.21 [0.47-3.10],0.6973964318263871
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23863,38,2.50 [0.92-6.81],0.0733864527906387
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24170,174,0.84 [0.52-1.33],0.4505628980356116
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24270,61,2.37 [1.08-5.19],0.0309822680444887
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24145,149,0.75 [0.45-1.23],0.2539495828338451
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,23349,62,2.54 [1.21-5.32],0.0134181745147076
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20863,183,1.15 [0.72-1.84],0.5638228002267501
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22615,109,0.85 [0.47-1.54],0.5949766363095481
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22633,127,1.99 [1.11-3.57],0.0205641601093804
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20713,33,1.58 [0.51-4.84],0.4266512006425235
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22578,62,1.40 [0.62-3.16],0.4199928532750262
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,22267,127,0.85 [0.49-1.47],0.5624618380902413
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",24210,142,0.52 [0.32-0.87],0.0117347199891079
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,24115,47,0.57 [0.24-1.37],0.2096530962185915
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,24099,31,1.52 [0.48-4.80],0.4739325377575621
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23975,1459,1.09 [0.92-1.28],0.3239628622467906
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21783,1419,1.09 [0.93-1.29],0.2998100801408793
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20719,39,2.25 [0.81-6.28],0.1220544184124613
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22894,51,1.48 [0.61-3.61],0.3905916155107773
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20847,167,1.19 [0.73-1.94],0.4874430961508927
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20734,54,0.66 [0.29-1.50],0.3205159300569975
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22804,2124,1.30 [1.13-1.49],0.0002380025163698
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20790,110,1.87 [1.03-3.42],0.0408376618786726
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,21029,349,1.09 [0.78-1.52],0.6269975275232356
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24253,230,0.92 [0.61-1.38],0.6823711025318726
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,24117,94,0.67 [0.36-1.25],0.2124238275961776
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20773,93,1.43 [0.73-2.78],0.2974452681875955
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20715,35,1.40 [0.48-4.09],0.5408064546312914
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23971,1128,1.10 [0.92-1.33],0.2963565121414144
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20794,114,1.32 [0.72-2.40],0.3706067501971134
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20817,137,1.16 [0.67-2.01],0.5956819083074931
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21028,348,1.43 [1.01-2.02],0.0427640296224332
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20736,56,0.63 [0.28-1.44],0.2776191856948452
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,24111,88,0.64 [0.34-1.22],0.1748200467402639
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20948,268,0.92 [0.63-1.35],0.6704265545609152
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20956,276,1.18 [0.81-1.72],0.4020679200111695
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,22193,53,1.78 [0.75-4.23],0.1927813322137877
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23724,3044,1.22 [1.09-1.37],0.0007811404891964
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22869,26,0.70 [0.22-2.21],0.5473137544893751
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22893,50,1.40 [0.58-3.41],0.4557879054020323
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24181,1716,1.00 [0.86-1.16],0.9668524461154838
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24184,1713,0.99 [0.85-1.15],0.8639389304681209
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22874,31,2.32 [0.73-7.34],0.1529444426748848
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,24054,1094,1.21 [1.00-1.46],0.0461181027162437
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21482,802,1.20 [0.96-1.51],0.1052618338613029
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24332,112,0.61 [0.34-1.08],0.0884178334581643
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,24098,30,2.07 [0.64-6.71],0.2253135506354777
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,23042,82,1.88 [0.94-3.77],0.07380707541923
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,23056,96,1.10 [0.58-2.07],0.7753433649058175
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20790,110,1.07 [0.59-1.93],0.8247955674191282
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22738,108,0.85 [0.47-1.56],0.6083587953119418
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1522,57,1.79 [0.73-4.40],0.2029586677294346
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1621,169,1.60 [0.96-2.67],0.07006155443069
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22666,36,5.21 [1.77-15.34],0.0027592580447953
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1497,32,2.08 [0.64-6.68],0.221130311732199
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23977,1347,1.18 [0.99-1.40],0.0697007462795003
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,24130,62,0.85 [0.39-1.89],0.6958336748460037
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22388,248,1.29 [0.87-1.92],0.2061132424166056
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21045,365,0.99 [0.72-1.38],0.9710596845602284
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24260,151,1.15 [0.69-1.93],0.5928483593070442
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23674,49,1.91 [0.73-4.97],0.1850304164637841
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Angina pectoris,23221,710,1.27 [0.99-1.61],0.0568930065149289
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23718,93,2.50 [1.26-4.96],0.0087880509812869
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23653,28,1.78 [0.50-6.35],0.3772057727645421
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23721,96,1.25 [0.65-2.42],0.5070027566117741
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17260,805,1.19 [0.94-1.49],0.141969351376213
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,AV-block,22148,161,0.97 [0.59-1.61],0.9046303414598026
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24311,229,1.14 [0.75-1.73],0.5473199895465461
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Cardiac arrest,16552,97,0.57 [0.31-1.06],0.0780503853397021
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Cardiomyopathy,22103,116,1.30 [0.72-2.37],0.3850913720682162
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",22062,75,1.55 [0.73-3.25],0.2512284538953774
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24343,15,0.64 [0.13-3.15],0.5812249016185287
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Conduction disorders,22459,472,0.99 [0.74-1.33],0.9661067962428186
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23695,1194,1.14 [0.95-1.38],0.1569836802517358
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22611,5364,1.08 [0.99-1.18],0.0883254219083369
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23323,159,1.11 [0.67-1.84],0.6816584363659273
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Endocarditis,22028,41,1.87 [0.67-5.25],0.2327350387512004
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24236,456,1.51 [1.11-2.05],0.0085229366898614
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Hypertension,23114,4370,1.11 [1.01-1.22],0.0327297736624553
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23122,4378,1.11 [1.01-1.23],0.0295476479568059
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24181,49,0.62 [0.25-1.49],0.2806209043611631
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18824,80,1.17 [0.57-2.40],0.659732321481691
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18785,41,0.52 [0.20-1.33],0.1741609494712363
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Hypotension,24253,611,0.98 [0.76-1.26],0.8489307655804061
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23869,57,0.81 [0.35-1.85],0.609547536047865
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23844,1333,1.10 [0.92-1.31],0.2825352719761578
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",24143,278,0.97 [0.66-1.41],0.8566724409848604
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Left bundle-branch block,22170,183,0.96 [0.60-1.53],0.8604106985836784
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24120,537,1.14 [0.86-1.51],0.356519716287741
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22948,437,1.16 [0.86-1.59],0.3337504634599399
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24293,104,1.97 [1.02-3.78],0.0426355905360946
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24329,181,1.17 [0.73-1.89],0.5078303899903209
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Oesophageal varices,23195,31,0.94 [0.30-2.95],0.9169116953888568
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other aneurysm,23666,41,0.77 [0.30-2.00],0.5907418477428139
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other arrhythmias,22208,221,0.78 [0.52-1.19],0.2513181269760254
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23685,60,1.41 [0.60-3.28],0.4307397709017239
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23756,131,1.42 [0.81-2.49],0.2165620110846784
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,22100,113,1.22 [0.67-2.21],0.5145088687754502
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other disorders of veins,23228,64,0.73 [0.34-1.56],0.4115568247769146
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,23210,46,1.17 [0.46-2.97],0.7347888391422119
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23648,35,0.76 [0.26-2.22],0.6212863788380967
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,23245,81,0.84 [0.42-1.67],0.620813427923639
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22513,526,1.02 [0.77-1.35],0.8928956341043084
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23684,42,0.54 [0.21-1.39],0.2031593360770459
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23934,309,0.94 [0.66-1.34],0.7269336169548772
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23942,137,1.09 [0.63-1.87],0.7665882980367287
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23820,207,0.54 [0.36-0.82],0.0042089112017422
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16669,214,1.01 [0.66-1.56],0.9522420947183848
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23786,183,1.10 [0.69-1.78],0.6829002760275775
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23382,218,0.92 [0.60-1.41],0.7032766522013192
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Pulmonary embolism,24104,299,1.04 [0.72-1.51],0.814570659270061
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24303,286,1.19 [0.82-1.74],0.3640382307363347
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Right bundle-branch block,22138,151,0.68 [0.41-1.13],0.13359356805688
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23939,134,1.11 [0.64-1.92],0.717461825098029
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23716,103,0.74 [0.40-1.36],0.3242921923808635
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",24136,324,0.92 [0.65-1.30],0.6379059055695073
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",24116,358,0.85 [0.61-1.18],0.325514724487471
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23853,52,0.56 [0.24-1.27],0.1645106915655866
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23673,49,1.61 [0.63-4.11],0.3206375903918069
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23982,117,0.72 [0.41-1.26],0.2478446931117738
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23743,160,1.05 [0.63-1.74],0.8545360261090161
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Varicose veins,23435,271,0.70 [0.48-1.01],0.0561570495242246
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23636,46,0.58 [0.24-1.41],0.2288915620701557
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter IX Diseases of the circulatory system,Venous thromboembolism,24188,463,0.95 [0.71-1.27],0.7215102167896106
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24198,330,1.71 [1.20-2.46],0.0033786301097232
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21663,1255,1.27 [1.06-1.51],0.0083927460560176
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Any mental disorder,23665,3257,1.15 [1.03-1.29],0.0108605444112977
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24144,388,1.52 [1.09-2.11],0.0137009622825432
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21897,1489,1.10 [0.93-1.29],0.2625283392308789
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20484,76,0.64 [0.32-1.26],0.1956743589981042
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Smoking dependency,23856,1368,1.28 [1.08-1.52],0.0045768312077032
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21980,1572,1.39 [1.18-1.63],8.716862396850985e-05
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter V Mental and behavioural disorders,Vascular dementia,24242,18,0.83 [0.19-3.74],0.8102539864687797
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Alzheimer disease,24342,65,0.77 [0.36-1.65],0.5065128978922508
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Bell's palsy,22865,67,0.54 [0.26-1.12],0.0964911871197976
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,23221,423,0.70 [0.52-0.93],0.0154803509843366
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Cerebral cysts,24024,180,1.10 [0.69-1.75],0.6951112975073521
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24265,201,0.85 [0.55-1.32],0.461320931383677
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,24208,22,2.25 [0.59-8.65],0.2367305001522009
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24331,50,1.01 [0.41-2.48],0.977861323092344
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23896,52,0.97 [0.41-2.32],0.9444925616353476
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Epilepsy,22973,232,0.54 [0.37-0.80],0.0022195386028087
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23909,1168,0.79 [0.66-0.94],0.0091532206836321
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24316,169,0.87 [0.54-1.40],0.5620153503827029
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23894,1474,1.15 [0.98-1.36],0.0915948470691733
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Generalized epilepsy,24014,48,0.34 [0.15-0.77],0.0101103782176317
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Hemiplegia,24213,149,0.86 [0.51-1.43],0.5544145304962262
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Hydrocephalus,23888,44,1.12 [0.43-2.90],0.8202714835362057
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24320,61,0.95 [0.43-2.11],0.9037945513966654
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22864,66,0.41 [0.21-0.81],0.0102592745275408
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22872,74,1.15 [0.55-2.42],0.710004543689744
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Memory loss,24208,65,0.45 [0.22-0.94],0.0330571628041083
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Migraine,23102,361,1.10 [0.79-1.52],0.5784630644690656
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24263,325,1.10 [0.78-1.55],0.5769826205584749
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Motor neuron disease,17684,92,0.75 [0.39-1.43],0.3781026462986512
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24150,132,0.52 [0.32-0.86],0.0111705644366308
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23803,1005,0.81 [0.67-0.99],0.0373777220099559
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Neurological diseases,23056,2685,0.82 [0.73-0.92],0.0009714218137961
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,24255,69,0.63 [0.30-1.32],0.2195315986585791
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",23148,350,1.09 [0.78-1.52],0.6168988055468906
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24281,200,1.41 [0.89-2.22],0.1438020872627
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20302,285,0.61 [0.43-0.87],0.0064102425864111
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23898,54,0.80 [0.35-1.86],0.6072791608540953
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23947,103,1.37 [0.73-2.58],0.3255653241996545
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,24219,72,1.41 [0.67-2.98],0.3653598755913996
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22882,84,0.47 [0.25-0.90],0.0225806352356893
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other headache syndromes,22798,57,0.70 [0.32-1.56],0.3837955368140735
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other neurological diseases,24234,390,0.88 [0.65-1.21],0.4367530276504761
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Other sleep disorders,23256,515,0.78 [0.59-1.02],0.0706075246181286
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Parkinson's disease,24330,76,0.55 [0.27-1.12],0.0987518710532468
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23900,56,1.25 [0.55-2.84],0.5980375201578572
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Restless leg syndrome,24342,34,1.16 [0.40-3.33],0.7846214936957079
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Sleep apnoea,24119,446,0.82 [0.61-1.10],0.1850209323763691
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24111,30,1.68 [0.51-5.52],0.3940514103044948
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24326,117,0.80 [0.45-1.42],0.4455608425730398
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22825,27,1.27 [0.38-4.23],0.6955509055340809
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24342,66,0.76 [0.36-1.61],0.4676948579197187
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),24230,17,0.88 [0.19-4.18],0.8734692599379371
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23912,36,1.64 [0.57-4.70],0.3567018969100686
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,24023,191,0.80 [0.52-1.25],0.3374955956752443
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24266,172,1.61 [0.98-2.66],0.0619499488787204
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23678,34,0.69 [0.25-1.93],0.4789455737809857
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23710,66,1.21 [0.56-2.62],0.6292817169174731
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24262,28,0.78 [0.25-2.47],0.670834003368667
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,24173,58,0.58 [0.27-1.28],0.1765803604556939
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1500,35,2.06 [0.67-6.28],0.2045708527650054
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1774,69,1.47 [0.66-3.29],0.3433707239996824
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23950,74,0.90 [0.44-1.87],0.7829028597657235
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24236,554,1.44 [1.09-1.88],0.0090055316686286
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",24067,423,0.96 [0.71-1.29],0.775161432175343
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23769,125,0.97 [0.56-1.67],0.9043889165430636
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24262,430,0.89 [0.66-1.20],0.4327566052068629
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24334,51,0.70 [0.30-1.65],0.4199056249859124
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24193,361,0.83 [0.60-1.15],0.2730696246516678
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24305,190,0.79 [0.51-1.23],0.2936191824390797
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24284,122,1.09 [0.62-1.91],0.7694112462927637
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23659,15,2.09 [0.39-11.23],0.3910016903240269
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23670,26,2.37 [0.67-8.37],0.1811715912883343
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23674,30,2.23 [0.72-6.86],0.1628728596793062
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24300,334,1.01 [0.72-1.43],0.9324622553810116
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,24049,83,0.68 [0.35-1.32],0.256411319322418
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23854,22,0.63 [0.18-2.26],0.4825642719646693
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,24176,61,0.87 [0.39-1.94],0.7381524712458194
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24246,131,0.83 [0.48-1.41],0.4841579202886298
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23979,147,0.88 [0.53-1.47],0.6324683709099614
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24232,70,1.25 [0.59-2.63],0.5601271715077556
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,24183,217,1.15 [0.75-1.77],0.5294788949899251
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23976,100,0.62 [0.34-1.13],0.1196482451064578
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23714,949,1.08 [0.88-1.33],0.454920550131657
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24224,109,0.81 [0.45-1.46],0.4845407387579956
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24320,98,1.72 [0.91-3.26],0.0980117936403614
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23878,234,0.98 [0.65-1.48],0.937167478727507
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,24150,35,0.84 [0.29-2.41],0.7465008238621695
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24318,35,0.56 [0.20-1.54],0.2628972655000611
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23679,35,0.40 [0.16-1.05],0.064151917245583
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23747,103,0.99 [0.53-1.83],0.9709595129494488
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23738,56,1.12 [0.48-2.61],0.7986475148346637
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23883,51,1.28 [0.53-3.07],0.5838126614853276
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23731,49,1.46 [0.59-3.62],0.4094139417660615
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,24013,47,1.21 [0.49-2.99],0.6833452238779453
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",24045,79,0.93 [0.46-1.89],0.8406417129803734
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23719,75,1.05 [0.51-2.17],0.8860050603248576
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23790,108,1.80 [0.98-3.32],0.0585821336526484
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23713,31,1.51 [0.47-4.83],0.4837723579681339
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23495,730,0.97 [0.77-1.22],0.7983902631146869
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23689,45,0.88 [0.36-2.15],0.7774948276655834
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,24149,273,0.76 [0.53-1.10],0.1483355543777857
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23907,31,0.97 [0.31-3.06],0.9644743375718636
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23985,109,0.66 [0.37-1.18],0.1589851086220207
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,24159,54,0.62 [0.28-1.38],0.2387531421353912
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24305,82,1.51 [0.75-3.05],0.2457474759339886
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24234,124,0.71 [0.42-1.23],0.223547950505066
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,24156,51,1.08 [0.45-2.60],0.8639879127045456
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,24156,51,0.58 [0.25-1.32],0.1923955817373766
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24260,476,0.95 [0.72-1.27],0.7486819122443416
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,24078,294,0.91 [0.63-1.31],0.6173131206325644
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23873,89,0.96 [0.50-1.87],0.9114991081726928
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23852,68,1.44 [0.66-3.12],0.3566231903823931
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Acute pharyngitis,24081,70,0.84 [0.40-1.73],0.6292303680734732
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24224,213,0.86 [0.57-1.31],0.4913569724492629
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,24068,57,0.80 [0.35-1.80],0.5864217890462053
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,All influenza,23180,70,0.59 [0.29-1.21],0.1504158954694272
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),23179,69,0.62 [0.30-1.28],0.1944954424650682
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17992,118,1.55 [0.86-2.80],0.1403745374776339
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Allergic rhinitis,24217,280,1.09 [0.75-1.59],0.6471478372674943
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19297,1556,1.01 [0.87-1.19],0.8656299074998307
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19400,1526,1.02 [0.87-1.20],0.7733539702170638
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),24087,90,1.28 [0.66-2.51],0.4645943146980709
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",23162,52,0.94 [0.40-2.21],0.8790846358521858
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Bronchiectasis,21640,156,1.32 [0.80-2.19],0.2766379027284241
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21519,35,1.43 [0.48-4.30],0.5186644085919294
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23562,2078,0.99 [0.87-1.14],0.9217385960031976
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23028,61,0.71 [0.33-1.56],0.3980179534528592
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Chronic sinusitis,23114,147,0.74 [0.45-1.23],0.2428398323337666
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24250,642,1.11 [0.86-1.43],0.4094967565495889
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Deviated nasal septum,23089,122,0.97 [0.55-1.73],0.927342665120772
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22626,3759,0.95 [0.85-1.05],0.2860657657453159
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23310,343,0.75 [0.54-1.05],0.0957256947697035
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Early onset COPD,24066,458,1.16 [0.87-1.57],0.315755403585836
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Emphysema,21652,168,1.32 [0.80-2.18],0.2853410844418963
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23200,102,0.72 [0.39-1.32],0.2924035375176718
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24178,1068,1.07 [0.88-1.30],0.4744554244467575
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Interstitial lung disease,23222,124,0.95 [0.54-1.65],0.8437489403876899
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Later onset COPD,23042,184,1.02 [0.63-1.64],0.9412624214614248
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24335,138,0.90 [0.53-1.53],0.6929741990586978
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Nasal polyp,23070,103,0.52 [0.29-0.94],0.0300089982068394
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24150,565,1.05 [0.81-1.37],0.7159749525443253
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other diseases of pleura,24180,1110,1.08 [0.89-1.30],0.446907966817938
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23766,799,0.87 [0.70-1.09],0.2287714249398327
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other pleural conditions,23103,33,0.44 [0.16-1.22],0.1161718268058448
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24288,182,1.04 [0.65-1.65],0.8781457605172617
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24268,763,1.02 [0.81-1.28],0.8958787685560298
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pleural effusion,23607,537,1.21 [0.92-1.60],0.1736621071097028
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pleural plaque,23115,45,0.63 [0.25-1.61],0.3357835922983213
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23988,878,1.06 [0.86-1.32],0.5795987305692858
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24317,120,0.91 [0.51-1.62],0.7492118904185726
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pneumothorax,23126,56,0.49 [0.22-1.06],0.0685987965245353
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pollen allergy,24315,242,1.17 [0.78-1.76],0.4359881993729928
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Pulmonary oedema,24142,36,0.85 [0.30-2.41],0.7620410891032605
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17907,33,1.06 [0.35-3.20],0.9150318562649812
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24130,545,1.06 [0.81-1.39],0.6735968794692166
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23247,280,1.08 [0.74-1.57],0.6797117043441867
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Viral pneumonia,23277,167,0.83 [0.51-1.34],0.4413023966189694
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",24101,144,0.89 [0.53-1.51],0.6770380457780005
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13998,88,0.86 [0.44-1.69],0.6712811008489075
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18614,58,1.01 [0.44-2.33],0.975133876624118
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Acute appendicitis,24160,134,0.64 [0.38-1.08],0.0937193540662015
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Acute gastritis,19427,60,1.42 [0.63-3.23],0.4015212551492343
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Acute pancreatitis,22900,154,0.94 [0.56-1.56],0.8031597795249759
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Acute peritonitis,23935,59,0.44 [0.21-0.94],0.0347939640849665
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23651,79,1.00 [0.49-2.05],0.9997012105791232
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Barrett oesophagus,19679,312,1.50 [1.05-2.16],0.027044425775922
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22798,52,0.67 [0.28-1.56],0.352646673889184
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23982,52,0.67 [0.29-1.56],0.3508449791142014
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Cholecystitis,22906,160,1.13 [0.68-1.87],0.636168064767723
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Cholelithiasis,23584,838,1.17 [0.94-1.45],0.1542392671341257
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Chronic gastritis,19590,223,0.90 [0.59-1.36],0.6076260985264312
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22786,40,1.36 [0.49-3.78],0.5503269288902284
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24209,77,0.84 [0.41-1.72],0.6347586162461152
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Coeliac disease,23068,100,1.04 [0.56-1.93],0.8977320684008171
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Collagenous colitis,22950,50,1.17 [0.48-2.85],0.7245272736356381
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24170,185,0.86 [0.54-1.35],0.5055394911436484
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Constipation,24151,1023,0.98 [0.81-1.20],0.8760546071721839
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Crohn disease,22983,83,1.06 [0.54-2.10],0.865066777367683
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",24033,56,1.05 [0.45-2.43],0.9107411088285756
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22979,79,1.05 [0.52-2.12],0.8831884175997473
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Dental caries,23606,233,1.11 [0.74-1.67],0.6188828462111211
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22479,1606,0.98 [0.84-1.14],0.7851916570669728
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of appendix,24199,173,0.68 [0.43-1.07],0.0945340805674784
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of liver,24233,661,1.03 [0.81-1.32],0.8109917973518331
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22794,3427,1.02 [0.91-1.13],0.7474901274379173
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23913,540,0.99 [0.76-1.29],0.931262717573005
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24266,390,1.08 [0.79-1.49],0.6241719123855287
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23487,114,1.12 [0.62-2.03],0.6971984491993178
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23349,61,1.06 [0.47-2.36],0.8896740261583177
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of the digestive system,24087,1119,1.16 [0.96-1.40],0.1230590131393923
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diseases of tongue,23355,109,0.79 [0.44-1.43],0.4422563603998586
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23885,1139,1.06 [0.88-1.28],0.5052721270435336
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20714,2158,1.14 [0.99-1.30],0.0673038480793618
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Duodenal ulcer,19500,133,1.01 [0.59-1.76],0.9594914692198032
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24276,102,1.16 [0.61-2.18],0.6556298140927108
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24225,74,1.31 [0.63-2.69],0.4683290711497652
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23667,95,1.00 [0.52-1.91],0.9896520674959024
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18714,158,0.80 [0.49-1.31],0.378123199443346
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Functional dyspepsia,19824,457,1.00 [0.75-1.34],0.9933547204784728
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastric ulcer,19621,254,0.82 [0.56-1.21],0.3257663356073657
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21359,1992,1.00 [0.87-1.15],0.9817703386972112
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19738,371,0.88 [0.64-1.22],0.444772012842744
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19808,7085,1.03 [0.96-1.11],0.3687517421339636
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,GI-bleeding,23863,895,1.18 [0.95-1.45],0.1320617997922661
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23435,62,0.74 [0.34-1.62],0.4547956066872366
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19360,1131,0.98 [0.82-1.19],0.8674368138864508
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23619,47,0.59 [0.24-1.44],0.2482844567119736
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Hernia,23295,2422,0.99 [0.87-1.12],0.870863171943571
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Impacted teeth,24234,69,1.35 [0.64-2.87],0.4304129894085927
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Impaction of intestines,18588,32,0.52 [0.18-1.47],0.2142304510670958
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Inguinal hernia,21478,605,1.01 [0.77-1.31],0.9684102991373722
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20944,71,0.84 [0.39-1.80],0.6574745861904058
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18621,65,1.50 [0.68-3.31],0.3181735537673874
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Intestinal malabsorption,23089,121,1.06 [0.60-1.86],0.8452895864985517
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19072,516,1.00 [0.76-1.32],0.98371933161999
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24317,342,1.08 [0.76-1.52],0.6771409419056441
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23524,624,1.22 [0.95-1.57],0.1181872360755761
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23683,783,1.15 [0.92-1.44],0.2224234969188711
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19494,127,0.55 [0.32-0.94],0.0277821654765057
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Oesophagitis,19802,435,1.35 [0.99-1.83],0.0555914409677594
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24304,120,1.24 [0.70-2.20],0.4622644096639418
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20917,44,0.75 [0.30-1.89],0.5407310485247814
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19706,1150,1.09 [0.91-1.31],0.3608812786394857
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22926,180,0.77 [0.49-1.22],0.2629177428626612
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22888,142,1.37 [0.80-2.33],0.2486859675251257
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of intestine,19894,1338,1.21 [1.02-1.44],0.0313731202807627
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of intestines,22874,4318,1.03 [0.94-1.14],0.5051759102298361
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23354,174,0.98 [0.61-1.57],0.9353216951441824
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of liver,24101,529,1.15 [0.87-1.52],0.3190074433757539
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19845,478,1.26 [0.94-1.69],0.1172559748033166
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22822,76,0.76 [0.38-1.54],0.4486561550974729
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24220,344,1.30 [0.93-1.83],0.1276341719073244
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20045,678,0.96 [0.76-1.22],0.7396272750450986
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23877,909,1.18 [0.96-1.45],0.124459731534765
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23523,150,0.81 [0.49-1.33],0.4010559378984111
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19624,1068,0.99 [0.82-1.20],0.9509317197860856
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20932,1565,1.03 [0.88-1.20],0.7573092828087641
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23648,76,0.64 [0.32-1.28],0.2032781901716759
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23583,683,1.23 [0.97-1.57],0.0872715365923863
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18768,212,0.99 [0.65-1.53],0.9765968329606364
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24209,86,1.14 [0.58-2.22],0.7022726434542319
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18868,312,0.96 [0.67-1.37],0.8186952103044809
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",23093,125,1.11 [0.63-1.95],0.7150358678164219
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24333,55,0.53 [0.24-1.17],0.1148856139511803
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23385,114,0.66 [0.38-1.16],0.1478385852441366
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Toxic colitis,22923,23,1.48 [0.39-5.59],0.5632136898784925
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19536,169,1.45 [0.88-2.37],0.142604311389466
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Ulcerative colitis,23033,133,1.06 [0.62-1.82],0.8251683691876562
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",23015,115,1.20 [0.67-2.15],0.5370318386387143
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Umbilical hernia,21117,244,0.91 [0.61-1.37],0.6626021977720574
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18653,97,0.67 [0.36-1.24],0.2014196905853135
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Ventral hernia,21084,211,1.28 [0.83-1.99],0.2646710947492962
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XI Diseases of the digestive system,Volvulus,18613,57,0.75 [0.33-1.68],0.4778888035134265
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24302,142,1.29 [0.76-2.19],0.3508707628936822
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,24107,74,1.07 [0.52-2.23],0.8524448147770872
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,23020,135,1.05 [0.62-1.78],0.8654500448196764
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23768,491,1.12 [0.84-1.49],0.4462844717414322
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23460,183,0.97 [0.61-1.55],0.9015011257792128
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,23037,152,1.15 [0.68-1.93],0.6007074486437864
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,24110,209,1.04 [0.68-1.60],0.8518809514565043
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24255,354,0.98 [0.70-1.36],0.9054837453455772
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23942,41,0.63 [0.25-1.59],0.3235143461211872
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,23034,2286,0.98 [0.86-1.12],0.8102012698761554
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23925,376,0.72 [0.52-0.98],0.0346529999198507
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23810,261,0.76 [0.52-1.11],0.1513960701166617
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23985,708,1.02 [0.80-1.29],0.897856932003636
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24331,41,0.85 [0.33-2.19],0.7311601300410931
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22939,54,0.92 [0.40-2.11],0.8463155287096813
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23588,39,0.52 [0.20-1.35],0.1810732467109764
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,24104,203,1.03 [0.67-1.60],0.8871077709181374
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,23154,269,1.01 [0.69-1.48],0.9591929332833936
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22917,32,1.44 [0.46-4.47],0.5284244246642349
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24267,66,0.85 [0.40-1.83],0.6797131686274284
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23396,119,1.09 [0.61-1.96],0.7601293477887734
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24166,133,1.35 [0.78-2.36],0.2870407233876654
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23926,25,2.94 [0.79-10.92],0.1064133622261429
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22931,46,1.00 [0.40-2.51],0.9965184109959296
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23883,998,1.09 [0.89-1.33],0.389953345619388
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",23183,298,1.01 [0.70-1.45],0.9615783626226456
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22921,36,1.36 [0.47-3.95],0.5703249386370983
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24268,235,1.23 [0.81-1.86],0.3285316656659575
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23956,55,0.85 [0.37-1.94],0.7059526829721532
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24225,192,1.28 [0.81-2.03],0.2865170222465985
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24315,155,1.16 [0.70-1.93],0.5604525943914136
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22998,113,1.01 [0.57-1.80],0.9736108783267936
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,23058,173,1.40 [0.86-2.27],0.1744253718332393
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24310,150,1.15 [0.69-1.93],0.5930705469871984
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",23001,116,1.47 [0.80-2.70],0.2140192187653407
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24311,110,1.39 [0.76-2.55],0.2826123384715949
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,21329,122,0.53 [0.31-0.90],0.0178691612884094
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22694,4129,0.80 [0.73-0.88],7.920728103156313e-06
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21492,2927,0.74 [0.66-0.83],1.7735615139870805e-07
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,21293,86,1.28 [0.65-2.54],0.4734712682077362
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21792,141,1.26 [0.74-2.15],0.4014145552597558
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21796,145,1.22 [0.72-2.06],0.4669007395808298
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,24136,106,0.65 [0.37-1.17],0.1506571164541542
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21694,43,1.14 [0.43-3.00],0.7983649013848777
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19249,684,0.72 [0.57-0.91],0.0057201502158659
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24284,117,0.61 [0.35-1.07],0.0828422816871402
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21908,257,0.81 [0.55-1.19],0.283353402290372
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21255,5545,0.83 [0.77-0.91],1.978524192233698e-05
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,23101,101,1.17 [0.62-2.20],0.6218910829938019
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,21318,111,0.91 [0.50-1.66],0.762690979296656
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21759,552,0.82 [0.64-1.07],0.1476044324511345
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23538,1887,0.91 [0.79-1.05],0.1904545306145594
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21412,205,0.95 [0.61-1.48],0.8263956593367268
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21471,264,0.93 [0.64-1.34],0.6810409364958824
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21344,137,1.83 [1.07-3.13],0.0273175024115662
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23858,36,0.63 [0.24-1.69],0.3608150089350068
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19722,1157,0.84 [0.70-1.01],0.0679922611942443
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18906,341,1.06 [0.74-1.52],0.7579024292781115
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24293,332,1.09 [0.76-1.57],0.6397258952222994
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18632,67,0.51 [0.25-1.05],0.0690686281232083
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18869,304,0.50 [0.36-0.69],4.202194570207932e-05
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21498,291,0.81 [0.56-1.15],0.2410440128546627
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19242,677,0.92 [0.72-1.17],0.4834343805692149
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21677,26,2.97 [0.81-10.90],0.1000696009713926
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,22150,499,0.84 [0.63-1.10],0.2072944646712916
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21906,255,1.00 [0.67-1.48],0.9898244548145402
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19193,628,0.94 [0.73-1.21],0.6402557455922011
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,21277,70,1.27 [0.60-2.70],0.531671564586488
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",21262,55,0.72 [0.32-1.62],0.4248718392064551
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,23055,55,1.53 [0.63-3.70],0.3433734485564582
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24046,1046,0.94 [0.78-1.13],0.5021258881380115
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23592,592,0.91 [0.71-1.17],0.474108888850093
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24235,307,0.83 [0.59-1.18],0.3087609809734053
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,20153,1588,0.70 [0.60-0.82],5.212018941869876e-06
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18632,67,0.36 [0.18-0.73],0.004669547489068
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,21275,68,0.87 [0.41-1.82],0.7079341360360514
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18590,25,0.46 [0.14-1.56],0.2148816511727448
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18667,102,1.13 [0.60-2.11],0.70390858468734
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23211,211,0.65 [0.43-0.98],0.0384574554155565
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,23219,219,1.29 [0.85-1.96],0.2376447743072369
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24306,77,0.88 [0.43-1.78],0.712386463327498
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",23058,1407,0.92 [0.78-1.09],0.3426078978781086
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21316,109,0.72 [0.41-1.28],0.2629285350815291
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18673,108,0.66 [0.37-1.17],0.1532129451572075
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,22222,571,0.97 [0.75-1.26],0.8042025624222857
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20379,1814,0.76 [0.66-0.88],0.0001693466070024
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23879,57,0.57 [0.26-1.23],0.1524954502671758
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24317,70,0.94 [0.45-1.98],0.8699305654873477
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21277,70,1.07 [0.50-2.29],0.856973299509855
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",22192,985,0.84 [0.69-1.02],0.0869409940375393
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,21271,64,0.69 [0.32-1.48],0.3388677996926972
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19576,1011,0.92 [0.75-1.12],0.3999047016785433
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,23095,95,0.89 [0.47-1.67],0.7102093561028968
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,21266,59,0.41 [0.19-0.87],0.0201681954631815
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21754,103,1.13 [0.61-2.10],0.6956272305959703
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21556,349,0.78 [0.56-1.09],0.1486756024117482
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,24014,192,0.99 [0.63-1.53],0.9512410313467752
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,22078,427,1.07 [0.79-1.45],0.6590110028605449
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24244,295,0.89 [0.63-1.28],0.5366261328472693
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24325,35,1.44 [0.49-4.17],0.5068754498935263
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21394,187,0.76 [0.49-1.19],0.2269082920174769
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19478,547,0.78 [0.60-1.02],0.0656123071057449
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21654,447,0.91 [0.68-1.21],0.5050318107080436
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21359,152,1.13 [0.67-1.90],0.6546516257832729
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18599,34,1.23 [0.41-3.67],0.709672452042166
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,20144,1579,0.91 [0.77-1.06],0.2191484584547355
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18968,403,0.69 [0.51-0.94],0.0172160136381863
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23901,79,1.22 [0.60-2.48],0.5867036608137004
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24274,45,0.73 [0.29-1.80],0.4898619849477239
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22923,27,0.46 [0.15-1.42],0.1762185687028881
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18637,72,0.86 [0.41-1.81],0.6965629752570737
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21735,84,0.75 [0.39-1.47],0.4068610786926807
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18876,311,0.75 [0.53-1.06],0.1070826647468417
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21442,235,0.75 [0.50-1.12],0.1589143820290752
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21843,192,0.97 [0.62-1.51],0.880761043179587
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21745,94,0.50 [0.28-0.92],0.0256876965249721
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20548,41,0.38 [0.16-0.92],0.032427087855234
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24328,38,1.18 [0.43-3.27],0.747425929923117
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21739,532,0.82 [0.63-1.07],0.135918692707026
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23900,78,0.52 [0.27-0.99],0.0474185988754868
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23380,2173,0.81 [0.71-0.92],0.0014399955947712
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21309,102,0.61 [0.34-1.10],0.1013533053073464
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21976,325,0.94 [0.67-1.33],0.7417857662996742
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,23077,168,1.07 [0.66-1.74],0.7769366567087643
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21786,135,1.17 [0.68-2.02],0.5719260514494269
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22615,964,0.97 [0.79-1.18],0.7332771512255215
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22287,636,1.05 [0.82-1.34],0.7206825199434261
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],21245,38,0.91 [0.34-2.47],0.8542630440004533
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23964,142,1.28 [0.76-2.14],0.3571782293906738
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21346,139,0.91 [0.54-1.53],0.7107149077389867
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,21260,53,0.63 [0.28-1.42],0.2674987934129637
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18599,34,0.48 [0.17-1.34],0.1598317480124322
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23880,759,1.13 [0.90-1.43],0.2904148700078701
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9880,64,1.27 [0.60-2.69],0.5370791065646645
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13142,72,1.26 [0.62-2.59],0.5203670966737647
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24078,272,1.17 [0.79-1.73],0.4281937006591851
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23859,53,0.95 [0.39-2.31],0.9032448474296392
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23690,569,1.17 [0.90-1.53],0.2518781793817711
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24179,19,0.50 [0.13-1.95],0.3199512906171738
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,24189,164,0.97 [0.59-1.58],0.8942455607110007
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Cystitis,22349,138,0.81 [0.48-1.36],0.4160571167830503
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Dialysis,23163,42,0.65 [0.25-1.65],0.3614226402345842
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10517,1004,0.84 [0.69-1.03],0.1025713590526972
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13248,178,0.99 [0.64-1.56],0.9802786447368332
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Endometriosis,9931,115,1.56 [0.89-2.76],0.1215969258719415
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10150,334,1.14 [0.82-1.58],0.4422086747608004
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10191,375,1.06 [0.77-1.44],0.7355452278524113
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20498,3753,0.98 [0.88-1.08],0.6731726128031391
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24219,59,1.53 [0.67-3.51],0.3096249844313193
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Hydrocele,9583,70,0.81 [0.37-1.76],0.5920415659216902
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,23041,195,1.14 [0.72-1.79],0.5844374714094926
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10185,672,0.90 [0.70-1.16],0.4299907719172009
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13131,210,0.92 [0.61-1.38],0.6782704619553799
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9605,92,1.04 [0.52-2.06],0.921059086615908
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Irregular menses,13143,105,1.56 [0.86-2.81],0.1410926349564622
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10078,262,1.04 [0.72-1.50],0.8334121872595219
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22268,57,0.49 [0.22-1.06],0.0712363983890885
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11052,1236,1.10 [0.93-1.31],0.2752607607366813
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9559,46,0.92 [0.35-2.42],0.8723090145803258
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9901,85,0.64 [0.35-1.20],0.1682468115803456
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24333,36,1.74 [0.60-5.03],0.3030252352469877
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24337,43,1.00 [0.39-2.58],0.9975908018857832
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23565,1354,0.90 [0.76-1.07],0.2262895422460878
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22639,428,0.82 [0.61-1.11],0.2075301397498333
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,13126,56,0.66 [0.31-1.42],0.2895098468461278
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24295,270,1.00 [0.68-1.47],0.9910688547722006
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9652,139,0.88 [0.51-1.53],0.6631023806545973
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9618,105,1.26 [0.66-2.41],0.491267076699862
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9579,66,0.51 [0.24-1.11],0.0899481926412996
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24309,48,1.28 [0.52-3.15],0.5950759819183726
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,23207,996,0.89 [0.73-1.08],0.2220910291521477
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,13029,108,0.99 [0.56-1.76],0.9782765975084344
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9887,71,1.10 [0.54-2.27],0.7882749727846997
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",10022,206,1.55 [1.01-2.37],0.0449234500839501
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9868,52,0.61 [0.27-1.37],0.2348207279937657
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9910,94,2.10 [1.13-3.91],0.0191631733968183
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,23073,227,1.05 [0.69-1.60],0.8164036676482116
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,24119,94,1.05 [0.54-2.02],0.8923162448828653
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9973,157,1.21 [0.75-1.97],0.4368442537587607
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9887,71,1.35 [0.65-2.79],0.4169628964303041
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10187,371,0.99 [0.72-1.35],0.9333089119880223
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9874,58,0.80 [0.37-1.75],0.5775211302288543
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10150,334,0.94 [0.68-1.31],0.7178070323232613
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24202,42,0.73 [0.28-1.91],0.5237937863143791
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9614,101,0.66 [0.35-1.24],0.1947242692353718
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24181,1335,1.13 [0.95-1.34],0.1718216627528686
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22972,126,0.88 [0.51-1.51],0.6382663010569144
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,23180,59,0.83 [0.37-1.88],0.6602383615792226
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23869,63,1.03 [0.46-2.31],0.9383608938861776
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22362,151,1.01 [0.60-1.69],0.970075237218314
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24136,330,1.02 [0.72-1.46],0.8928779394717837
PGLYRP2,N-acetylmuramoyl-L-alanine amidase,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9901,85,0.83 [0.44-1.58],0.570031593537238
